Human Immunology News Volume 12.45 | Dec 03 2024

    0
    28







    2024-12-03 | HIN 12.45


    Human Immunology News by STEMCELL Technologies
    Vol. 12.45 – 3 December, 2024
    TOP STORY

    Safety and Activity of CTX130, a CD70-Targeted Allogeneic CRISPR-Cas9-Engineered CAR T Cell Therapy, in Patients with Relapsed or Refractory T Cell Malignancies (COBALT-LYM): A Single-Arm, Open-Label, Phase I, Dose-Escalation Study

    Researchers assessed the safety and activity of CTX130, a CD70-directed, allogeneic CAR immunotherapy manufactured from healthy donor T cells, in patients with relapsed or refractory T cell lymphoma.
    [Lancet Oncology]

    Abstract
    PUBLICATIONSListed by the impact factor of the journal

    Type 1 Immune Responses Related to Viral Infection Influence Corticosteroid Response in Asthma

    Researchers determined the frequency and within-patient variability of corticosteroid-responsive type 1 (T1)-high, T2-high, and T1/T2-high asthma endotypes and whether virally influenced T1-high disease influenced corticosteroid response in asthma.
    [American Journal of Respiratory and Critical Care Medicine]

    Abstract

    Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a Complex Human Immunodeficiency Virus Treatment Regimen: A Randomized, Open-Label, Multicenter Phase II Study (ARTISTRY-1)

    ARTISTRY-1 was a Phase II/III, operationally seamless, randomized, open-label, multicenter, active-controlled study. Phase II of the study enrolled adults with plasma HIV-1 RNA <50 copies/mL receiving a complex antiretroviral therapy regimen for ≥6 months.
    [Clinical Infectious Diseases]

    Full Article

    Dominant Negative Variants in ITPR3 Impair T Cell Ca2+ Dynamics Causing Combined Immunodeficiency

    The importance of calcium as a second messenger in T cell signaling was exemplified by genetic deficiencies of STIM1 and ORAI1, which abolished store-operated calcium entry resulting in combined immunodeficiency.
    [Journal of Experimental Medicine]

    Full Article

    Novel Tri-Specific T Cell Engager Targeting IL-13Rα2 and EGFRvIII Provides Long-Term Survival in Heterogeneous GBM Challenge and Promotes Antitumor Cytotoxicity with Patient Immune Cells

    Researchers described novel trivalent antibodies, DNA-encoded tri-specific T cell engagers, targeting two glioblastoma multiforme antigens, epidermal growth factor receptor variant III (EGFRvIII) and IL-13Rα2, and engaging T cells through CD3.
    [Journal for Immunotherapy of Cancer]

    Full ArticlePress Release

    Integrated Single-Cell Transcriptome and TCR Profiles of Hepatocellular Carcinoma Highlight the Convergence on Interferon Signaling during Immunotherapy

    Scientists comprehensively analyzed paired single-cell RNA transcriptome and T cell repertoire profiles from 14 hepatocellular carcinoma ascites samples, collected from seven patients before and after treatment with the combination of sintilimab and bevacizumab.
    [Journal for Immunotherapy of Cancer]

    Full Article

    Long-Term Follow Up in Anti-Contactin-1 Autoimmune Nodopathy

    Investigators analyzed long-term clinical and biomarker features of anti-contactin-1 (CNTN1) autoimmune nodopathy. Patients with anti-CNTN1+ autoimmune nodopathy detected in the laboratory from which clinical information was available were included.
    [Annals of Neurology]

    Abstract

    In Human CD4+ T Cells, Omeprazole Suppresses Proliferation, Downregulates V-ATPase, and Promotes Differentiation toward an Autoimmunity-Favoring Phenotype

    Triggered by findings indicating a correlation between proton pump inhibitors usage and susceptibility to infectious or autoimmune diseases, investigators studied the impact of a pharmacological concentration of omeprazole on human CD4+ T cells.
    [International Immunopharmacology]

    Abstract

    Assessing Human B Cell Responses to Influenza Virus Vaccines and Adjuvants in a PBMC-Derived In Vitro Culture System

    Scientists assessed whether B cells present in peripheral blood mononuclear cells responded to vaccines and reflected the effects of different vaccine formulations and adjuvants.
    [Vaccine]

    Full Article
    December 2024 Science Events
    REVIEWS

    Rheumatoid Arthritis: A Review of the Key Clinical Features and Ongoing Challenges of the Disease

    The authors provide a comprehensive overview of rheumatoid arthritis, covering new research on the ‘pre-clinical’ phase of the disease, as well as its epidemiology, pathogenesis, clinical manifestations, diagnosis, imaging, and management strategies.
    [Panminerva Medica]

    Abstract
    INDUSTRY AND POLICY NEWS

    Moffitt Patient Is First To Receive Second CAR T Therapy for Ovarian Cancer

    Marisol Gallagher, with Drs. Robert Wenham and Monica Avila, received a second round of CAR T-cell therapy 18 months after her first round. Her care team hopes the second infusion will cure her ovarian cancer once and for all.
    [Moffitt Cancer Center]

    Press Release
    FEATURED EVENT

    Translating Targeted Therapies in Combination with Radiotherapy

    January 26-29, 2025
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Bioinformatician – Rheumatic Diseases

    Cedars-Sinai Medical Center – Los Angeles, California, United States

    Postdoctoral Researcher – Prostate Cancer Immune Modulation

    University of Oxford – Oxford, England, United Kingdom

    PhD Positions – Infection Biology, Immunology, Microbiology, Parasitology, Epidemiology

    International Max Planck Research School for Infectious Diseases and Immunology – Berlin, Germany

    Postdoctoral Research Associate – Metabolism and TME Interactions during Cancer Progression

    Princeton University – Princeton, New Jersey, United States

    Faculty Position – Translational Cancer Research

    Northwell Health – Manhasset, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2